Fibroblast Growth Factor 21 and Metabolic Dysfunction in Women with a Prior Glucose-Intolerant Pregnancy

OBJECTIVE: We sought to determine if there is an association between fibroblast growth factor 21 (FGF21) levels and a history of gestational diabetes mellitus (GDM) in women with and without metabolic dysfunction, defined as a diagnosis of metabolic syndrome or type 2 diabetes (T2DM), 5 to 10 years...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Perinatol
Autors principals: Durnwald, Celeste, Mele, Lisa, Landon, Mark B., Varner, Michael W., Casey, Brian M., Reddy, Uma M., Wapner, Ronald J., Rouse, Dwight J., Tita, Alan T. N., Thorp, John M., Chien, Edward K., Saade, George R., Peaceman, Alan M., Blackwell, Sean C.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755696/
https://ncbi.nlm.nih.gov/pubmed/32575141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1712966
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars